GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
I

Isofol Medical AB (publ) ISOFOL.ST · SEK

Health Care · Nasdaq Stockholm · 🇸🇪 Sweden

Compare

1.58

+12.06%

Close of 9 Nov 2026, in SEK

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in SEK, from our data supplier.

FY2025

Revenue

—

FY2016FY2025

Net income

−SEK 54.2m

FY2016FY2025

Free cash flow

−SEK 103.9m

FY2016FY2025

Shareholders' equity

SEK 107.9m

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue——SEK 721,000SEK 12.8mSEK 22.4mSEK 37.1m——SEK 227,000SEK 508,000
Research and developmentSEK 39.9m—————————
Operating income−SEK 54.8m−SEK 47.2m−SEK 41.7m−SEK 167.5m−SEK 204.5m−SEK 188.8m−SEK 167.8m−SEK 89.8m−SEK 72.6m−SEK 64.0m
Net income−SEK 54.2m−SEK 43.5m−SEK 37.1m−SEK 159.8m−SEK 200.3m−SEK 189.0m−SEK 161.6m−SEK 83.1m−SEK 72.0m−SEK 64.0m
Diluted earnings per share-0.21-0.27-0.23-0.99-1.24-1.79-2.87-1.47-1.48-2.26

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsSEK 129.4mSEK 98.4mSEK 140.6mSEK 213.5mSEK 401.4mSEK 148.1mSEK 146.5mSEK 288.6mSEK 361.3mSEK 22.9m
Cash and short-term investmentsSEK 127.0mSEK 96.2mSEK 138.1mSEK 190.6mSEK 379.4mSEK 116.4mSEK 127.0mSEK 272.9mSEK 357.3mSEK 19.1m
Total liabilitiesSEK 21.5mSEK 20.5mSEK 19.2mSEK 55.0mSEK 83.1mSEK 81.6mSEK 41.6mSEK 23.5mSEK 18.2mSEK 16.8m
Debt———SEK 3.9mSEK 1.7mSEK 3.1mSEK 4.2m———
Shareholders' equitySEK 107.9mSEK 77.9mSEK 121.4mSEK 158.5mSEK 318.2mSEK 66.6mSEK 104.9mSEK 265.0mSEK 343.0mSEK 6.1m
Shares outstanding256m164m162m162m162m105m56m56m49m28m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations−SEK 51.9m−SEK 42.0m−SEK 52.5m−SEK 191.0m−SEK 188.4m−SEK 160.3m−SEK 147.2m−SEK 92.5m−SEK 61.9m−SEK 56.9m
Capital spending−SEK 51.9m—————−SEK 324,000−SEK 324,000−SEK 75,000−SEK 73,000
Free cash flow−SEK 103.9m−SEK 42.0m−SEK 52.5m−SEK 191.0m−SEK 188.4m−SEK 160.3m−SEK 147.5m−SEK 92.8m−SEK 62.0m−SEK 57.0m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Operating income−SEK 16.3m−SEK 15.6m−SEK 12.9m−SEK 13.6m−SEK 15.0m−SEK 14.1m−SEK 13.7m−SEK 11.7m
Net income−SEK 15.7m−SEK 15.1m−SEK 12.8m−SEK 13.1m−SEK 14.7m−SEK 13.7m−SEK 13.1m−SEK 10.9m
Diluted earnings per share-0.05-0.05-0.05-0.05-0.06-0.05-0.08-0.07
Cash from operations−SEK 14.0m−SEK 16.0m−SEK 11.0m−SEK 10.0m−SEK 17.0m−SEK 12.0m−SEK 8.0m−SEK 14.0m
Capital spending——−SEK 51.0m—————
Free cash flow——−SEK 62.0m—————
Total assetsSEK 118.6mSEK 113.9mSEK 129.4mSEK 142.1mSEK 69.1mSEK 84.5mSEK 98.4mSEK 110.1m
Cash and short-term investmentsSEK 114.8mSEK 110.7mSEK 127.0mSEK 138.8mSEK 65.7mSEK 82.1mSEK 96.2mSEK 104.0m
Shareholders' equitySEK 95.0mSEK 92.8mSEK 107.9mSEK 120.6mSEK 49.6mSEK 64.3mSEK 77.9mSEK 91.0m

Growth per year

Compound annual rate

3 years5 years10 years
Operating income-31.1%-21.9%3.0%
Net income-30.3%-22.1%2.9%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Price to earnings-3.4-8.4-3.2-0.8-1.2-1.9-0.6-1.4-1.3
Price to sales——163.59.310.39.8——413.5

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years. Last went ex-dividend on 14 Feb 2023.

FY2023
Paid in the year0.008

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.